SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-20-000524
Filing Date
2020-04-15
Accepted
2020-04-14 21:08:20
Documents
15
Period of Report
2020-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 13333
2 Q3 FINANCIAL STATEMENTS ex991.htm EX-99.1 907673
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 697172
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 19312
5 GRAPHIC logo.jpg GRAPHIC 37382
6 GRAPHIC logo_footer.jpg GRAPHIC 6516
7 GRAPHIC mda_brokencoast.jpg GRAPHIC 15184
8 GRAPHIC mda_cover.jpg GRAPHIC 269863
9 GRAPHIC mda_goodsupply.jpg GRAPHIC 8831
10 GRAPHIC mda_pg4.jpg GRAPHIC 21963
11 GRAPHIC mda_pg11.jpg GRAPHIC 137792
12 GRAPHIC mda_riff.jpg GRAPHIC 6369
13 GRAPHIC mda_solei.jpg GRAPHIC 21318
14 GRAPHIC mda_pg22.jpg GRAPHIC 44923
15 GRAPHIC mda_pg23.jpg GRAPHIC 11649
  Complete submission text file 0001279569-20-000524.txt   2441214
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 20792439
SIC: 2833 Medicinal Chemicals & Botanical Products